May 2, 2025 1Q 2025 Earnings Presentation Forward Looking Statements This presentation contains certain statements that may be deemed "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact, that address activities, events or developments that our management intends, expects, projects, believes or anticipates will or may occur in the future are forward-looking statements. Forward-looking state ...

Financial Performance - 1Q25 sales reached $378 million, a 12% increase compared to the prior year, driven by a 7% increase in volume and 4% favorable market-based pricing [2][5][8]. - Net income for 1Q25 was $23.3 million, an increase of $40.7 million year-over-year, with adjusted earnings per share of $0.93, up $1.49 from the previous year [5][11]. - Adjusted EBITDA for the quarter was $51.6 million, a significant increase of $51.0 million compared to the prior year, with an adjusted EBITDA margin of 13.7%, up 1,350 basis points [5][10]. - Total sales for Q1 2025 reached $377.791 million, a 12.1% increase from $336.829 million in Q1 2024 [25]. - Net income for Q1 2025 was $23.344 million, compared to a net loss of $17.396 million in Q1 2024, marking a significant turnaround [25]. - Adjusted EBITDA for Q1 2025 was $51.626 million, with an adjusted EBITDA margin of 13.7%, up from 0.2% in Q1 2024 [30]. - Basic earnings per share (EPS) for Q1 2025 was $0.87, compared to a loss per share of $(0.65) in Q1 2024 [31]. Cash Flow and Capital Expenditures - Cash flow from operations improved to $11.4 million, an increase of $47.6 million year-over-year, while free cash flow was ($22.6) million, an improvement of $49.0 million [5][11]. - Capital expenditures for 1Q25 were $34.1 million, a decrease of $1.3 million compared to the prior year, with expectations for total capital expenditures of $145 to $155 million in 2025 [5][15]. - The company reported a free cash flow of $(22.619) million for Q1 2025, an improvement from $(71.590) million in Q1 2024 [28]. - Cash and cash equivalents decreased to $8.344 million at the end of Q1 2025, down from $19.564 million at the end of Q4 2024 [27]. Assets and Liabilities - Total current assets increased to $418.182 million as of March 31, 2025, compared to $387.116 million at December 31, 2024 [24]. - Total liabilities rose to $831.606 million as of March 31, 2025, up from $820.270 million at December 31, 2024 [24]. Strategic Focus and Market Conditions - The company anticipates a pre-tax income impact of plant turnarounds to be $25 to $30 million in 2025, down from approximately $58 million in 2024 [15]. - Strong demand for sulfur nutrition and tight North American ammonium sulfate supply are expected to support sulfur premiums at or near the high end of historical ranges [15]. - The company is focused on disciplined cost and cash management while maintaining investments for sustainable long-term performance [13]. - The company continues to leverage its competitive position in nylon to navigate a protracted downturn in the cycle due to global oversupply conditions [15]. Dividends and Investments - A quarterly cash dividend of $0.16 per share was declared, payable on May 27, 2025 [14]. - The company plans to invest approximately $25-$30 million in sulfuric acid operations for FY 2025 [34]. - The company experienced an unfavorable impact of approximately $17 million to pre-tax income due to maintenance during a planned plant turnaround [36].

Core Viewpoint - AdvanSix Inc. reported a fourth-quarter earnings of $0.01 per share, a significant improvement from a loss of $0.19 in the same quarter last year, and adjusted earnings of $0.09 per share exceeded the Zacks Consensus Estimate of a loss of $0.37 [1][2] Financial Performance - Revenues for the fourth quarter were $329.1 million, down approximately 14% year over year, missing the Zacks Consensus Estimate of $377.2 million [2] - Sales volumes decreased around 16% primarily due to delayed ramp-up to full operating rates following a planned plant turnaround [2] - For the full year 2024, earnings were reported at $1.62 per share, down from $1.95 the previous year, with total sales falling about 1% year over year to approximately $1,517.6 million [4] Product Line Sales - Nylon sales were approximately $67.2 million, down around 14% year over year, below the consensus estimate of $81 million [3] - Caprolactam sales were around $57.2 million, down about 31% year over year, also below the consensus estimate of $77 million [3] - Chemical Intermediates sales remained flat year over year at $102.1 million, below the consensus estimate of $103 million [3] - Plant Nutrients sales fell roughly 14% year over year to around $102.6 million [3] Financial Position - AdvanSix ended the quarter with cash and cash equivalents of approximately $19.6 million, a decrease of about 34% year over year [5] - Long-term debt increased around 15% year over year to $195 million [5] - Cash flow from operations was $64 million for the quarter and $135.4 million for the full year 2024 [5] Market Outlook - The company anticipates strong demand for sulfur nutrition and tight ammonium sulfate supply in North America, which is expected to support sulfur premiums at or near historical highs [6] - Balanced global acetone supply and demand conditions are projected to maintain industry spreads above cycle averages [6] - A slower recovery is expected for the North American nylon industry due to stable end-market demand and increased domestic competition [6] Capital Expenditures - AdvanSix plans capital expenditures of $140-$160 million in 2025 [7] - The pre-tax income impact of plant turnarounds is expected to be $25-$30 million in 2025, compared to approximately $58 million in 2024 [7] Stock Performance - ASIX stock has gained 5.8% over the past year, contrasting with a 20.6% decline in the Zacks Chemicals Specialty industry [9]

Customer Concentration and Sales - The company's 10 largest customers accounted for approximately 38% of total sales in 2024, with the largest customer being Shaw, a major consumer of Nylon 6 resin and caprolactam[94]. - The company is exposed to risks associated with customer concentration, which could lead to significant financial impacts if major customers reduce their purchasing volumes[94]. Economic and Market Risks - The company faces significant risks from economic volatility, including inflation and potential recessionary pressures, which could adversely affect sales and margins[84]. - Competition in the industry is intense, with pressures on pricing and gross margins due to evolving market demands and regulatory changes[96]. - The company faces risks related to international trade policies that could increase costs or decrease demand for its products, adversely affecting its financial condition[132]. Operational Risks - The company relies heavily on third-party transportation for raw materials and product shipments, making it vulnerable to disruptions that could impact financial performance[93]. - Raw material price fluctuations, particularly for cumene, natural gas, and sulfur, are critical to the company's cost structure and could adversely affect profitability if not managed effectively[90]. - The company has experienced unplanned production interruptions in the past, which could lead to increased costs and loss of customer relationships[89]. - The capital-intensive nature of the industry may require the company to seek additional financing in the future, which may not be available on favorable terms[95]. - The company emphasizes the importance of maintaining production efficiency and controlling costs to offset potential decreases in pricing and profitability[82]. Regulatory and Environmental Risks - The company faces potential liabilities related to environmental hazards from past operations, which could result in substantial costs and negatively impact its financial condition[123]. - The company is subject to extensive environmental regulations that may impose additional costs and operational changes, potentially affecting its business performance[124]. - Climate change may lead to extreme weather conditions that could disrupt operations and increase costs, impacting the company's financial results[125]. - The company is impacted by increasing stakeholder interest in sustainability and ESG matters, leading to expanded reporting and investments in these areas[129]. Financial and Investment Risks - The company may need to record significant impairment charges related to goodwill, intangibles, and other long-lived assets, which could adversely affect its financial condition and results of operations[117]. - The company may face significant cash contributions to its defined benefit pension plan in the future, which could impact cash flow and financial condition[115]. - The company has not made pension contributions in 2024 but may need to in future periods to meet funding requirements[116]. - The company has restrictive covenants associated with its indebtedness that may limit its operational flexibility and ability to pursue strategic initiatives[120]. - The market price of the company's common stock may fluctuate significantly due to various factors, including market conditions and stockholder activism[139]. Strategic Initiatives and Partnerships - The company is actively evaluating acquisitions and strategic partnerships, which may present challenges and risks that could affect financial condition[104]. - The company’s ability to develop and commercialize new products and technologies is crucial for maintaining competitive advantage and meeting customer needs[96]. - The company emphasizes the importance of enhancing existing products and developing new technologies, which requires significant investment in R&D and marketing[98]. Cybersecurity and Legal Risks - Cybersecurity threats are increasing, and a successful attack could disrupt operations and adversely impact financial condition[112]. - Legal risks from litigation, including product liability and environmental claims, could materially impact financial results and brand value[101]. - The use of AI presents risks related to unauthorized disclosures and potential legal liabilities, which could adversely affect business operations[114]. Workforce and Operational Flexibility - Approximately 52% of the workforce is covered by collective bargaining agreements, which may impact operational flexibility and financial condition[110]. - The company relies on the recruitment and retention of qualified personnel, with competition for talent being intense, which could affect operations[111]. Financial Management and Stockholder Considerations - The company cannot guarantee the timing, declaration, amount, or payment of any dividends, which may be limited by the terms of its indebtedness[142]. - Stockholder percentage ownership in AdvanSix may be diluted due to common stock-based equity awards and potential equity issuance for capital raising or acquisitions[143]. - The existence of a share repurchase program may increase stock price volatility and does not obligate the company to repurchase any specific amount of shares[141]. - A 25-basis point fluctuation in interest rates for the year ended December 31, 2024, would result in an increase or decrease to interest expense of approximately $0.5 million based on current borrowing levels[272]. - Fluctuations in stock price could expose the company to litigation, resulting in substantial costs and management distraction[141]. Internal Controls and Governance - Failure to maintain effective internal controls could result in penalties or investigations, negatively impacting the company's stock price and financial reporting[133]. - Provisions in the company's Amended and Restated Certificate of Incorporation may discourage takeovers and prevent certain types of transactions[144]. - The spin-off could lead to significant tax liabilities for U.S. stockholders if it does not qualify for non-recognition of gain and loss under Section 355(e) of the Code[137].

Financial Data and Key Metrics Changes - Sales for Q4 2024 were $329 million, a decrease of approximately 14% compared to the prior year, with sales volume down about 16% due to delayed ramp-up following a planned turnaround [12][13] - Adjusted EBITDA for Q4 2024 was $10 million, down $5 million year-over-year, primarily due to plant turnaround timing, partially offset by favorable sales mix and insurance claim proceeds [13] - Adjusted earnings per share increased by $0.19 to $0.09, influenced by $9.7 million in carbon capture tax credits, reducing the effective tax rate to 3.1% for the full year 2024 [13][14] - Free cash flow for Q4 2024 was $30 million, up $8 million from the prior year, with cash flow from operations increasing by $4 million to $64 million [14] Business Line Data and Key Metrics Changes - The plant nutrients business showed strong performance, with ammonium sulfate prices in the corn belt up 15% year-over-year, while nitrogen pricing declined by 8% [22] - Nylon business faced persistent global oversupply, impacting pricing and spreads, with North American demand remaining stable but competitive behavior affecting spreads [26][28] - Chemical intermediates, particularly acetone, maintained healthy prices amid balanced global supply and demand, although demand for acetone in MMA markets remained soft [31] Market Data and Key Metrics Changes - The market for ammonium sulfate is robust, with a strong order book sold out into the second quarter of 2025, supported by rising grain and nitrogen fertilizer prices [22][36] - Natural gas and sulfur prices are expected to increase significantly year-over-year, impacting raw material costs and pricing strategies [34][35] - The competitive landscape in the nylon market is influenced by increased imports from Asia and stable domestic supply, leading to a slower recovery in pricing [28][85] Company Strategy and Development Direction - The company is focused on strategic growth priorities, including capital investments in expanding granular ammonium sulfate capacity and maintaining prudent debt leverage levels [8][17] - The company aims to improve through-cycle profitability by optimizing regional and product sales mix and promoting differentiated product offerings [40][41] - The company is pursuing carbon capture tax credits as a significant value driver, with expectations of continued growth in this area [10][20] Management's Comments on Operating Environment and Future Outlook - Management acknowledged operational performance did not meet expectations but highlighted resilience and strong cash flow performance [6][7] - The outlook for 2025 anticipates meaningful year-over-year earnings improvement, supported by operational excellence and strong commercial performance [39] - The macroeconomic environment remains favorable for the industries served, with expectations of strong sulfur premiums and a balanced acetone supply-demand environment [41] Other Important Information - The company received $5.3 million in insurance proceeds in Q4 2024 related to the 2019 PES QME supplier shutdown, totaling approximately $39 million in aggregated insurance proceeds since the event [9] - The company is recognized for its carbon capture efforts, claiming initial 45Q tax credits of $9.7 million for the 2018 and 2019 tax years [10][20] Q&A Session Summary Question: What is the maximum conversion level for granular production? - Management indicated a target conversion of 75% for the SUSPANE program, with no expectation to reach 100% due to market dynamics [46] Question: Is the phenol market still problematic for acetone production? - Management confirmed that phenol operating rates are around 65%, and the company is targeting higher rates due to strong integration into the caprolactam value chain [49] Question: What is the expected carbon capture output for 2025? - Management suggested a run rate of approximately $5 million for carbon capture credits, which could escalate with inflation adjustments [52] Question: Can you elaborate on the capital spending plans for 2025? - Management outlined a capital expenditure range of $140 to $160 million, with a significant portion directed towards growth projects and sustaining operations [62] Question: How are natural gas costs impacting competitiveness in the fertilizer market? - Management noted that energy costs are crucial for nitrogen producers, influencing global pricing dynamics and competitiveness [70] Question: What is the outlook for the broader agricultural portfolio beyond ammonium sulfate? - Management acknowledged challenges in the ag chemical space, particularly due to low-price competition and imports, contrasting with positive trends in dry fertilizers [92]

Financial Data and Key Metrics Changes - Sales for Q4 2024 were $329 million, a decrease of approximately 14% year-over-year, with sales volume down about 16% due to delayed ramp-up following planned turnarounds [10][11] - Adjusted EBITDA for Q4 2024 was $10 million, down $5 million from the previous year, primarily due to plant turnaround impacts [11] - Adjusted earnings per share increased to $0.09, up $0.19 year-over-year, influenced by $9.7 million in carbon capture tax credits [11] - Free cash flow for Q4 2024 was $30 million, an increase of $8 million compared to the prior year [12] Business Line Data and Key Metrics Changes - The Plant Nutrients business saw strong performance, with ammonium sulfate prices in the Corn Belt up 15% year-over-year, while nitrogen pricing declined by 8% [16][18] - Nylon business faced persistent global oversupply, impacting pricing and spreads, with North American demand remaining stable [20][21] - Chemical intermediates experienced healthy acetone prices, although demand for acetone in MMA markets was soft [22][23] Market Data and Key Metrics Changes - The market for ammonium sulfate is robust, with a strong order book sold out into Q2 2025, supported by rising grain and nitrogen fertilizer prices [18][26] - Anticipated higher raw material prices, particularly for natural gas and sulfur, are expected to impact overall pricing spreads in 2025 [24][25] Company Strategy and Development Direction - The company is focused on strategic growth priorities, including investments in granular ammonium sulfate capacity and maintaining prudent debt levels [6][29] - The company aims to improve through-cycle profitability by optimizing product sales mix and driving productivity [28][29] Management's Comments on Operating Environment and Future Outlook - Management acknowledged operational challenges in 2024 but expressed confidence in the company's ability to deliver improved earnings in 2025, supported by a resilient business model [29][71] - The macroeconomic environment remains largely favorable for the industries served, with expectations of strong sulfur premiums supporting plant nutrients [29] Other Important Information - The company received approximately $39 million in insurance proceeds related to the 2019 PES cumene supplier shutdown, with $5.3 million recognized in Q4 2024 [7] - The company claimed $9.7 million in 45Q carbon capture tax credits in Q4 2024, which significantly reduced the effective tax rate [8][15] Q&A Session Summary Question: On the conversion to granular ammonium sulfate - Management indicated a target conversion of 75% for granular production, aligning with North American domestic demand [32][33] Question: Phenol market conditions and acetone production - Management confirmed that they are running above industry rates for phenol, which supports acetone production amid lower phenol operating rates [34] Question: Future carbon capture estimates - Management suggested a potential run rate of $5 million to $6 million for carbon capture credits in the coming years, with inflation adjustments [36] Question: Capital spending breakdown for 2025 - Management outlined that capital expenditures for 2025 are projected between $140 million and $160 million, with a significant portion directed towards growth projects [46][48] Question: Natural gas costs and their impact on competitiveness - Management acknowledged that energy costs are crucial for nitrogen producers and that they are monitoring how these costs affect global trade dynamics [51][52] Question: Competitive pressures in the nylon market - Management noted that while demand remains stable, increased domestic supply has led to competitive pressures, particularly from imports [60][61] Question: Outlook for agricultural chemicals - Management indicated challenges in the ag chemical space, particularly due to low-price competition from Chinese imports [62]

Core Viewpoint - AdvanSix reported quarterly earnings of $0.09 per share, significantly beating the Zacks Consensus Estimate of a loss of $0.37 per share, marking an earnings surprise of 124.32% [1] - The company’s revenues for the quarter were $329.06 million, which fell short of the Zacks Consensus Estimate by 12.75% and decreased from $382.21 million year-over-year [2] Financial Performance - AdvanSix has surpassed consensus EPS estimates three times over the last four quarters [2] - The company had an earnings surprise of 33.33% in the previous quarter, with actual earnings of $0.88 per share compared to an expected $0.66 [1][2] - The current consensus EPS estimate for the upcoming quarter is $0.89, with projected revenues of $391 million, and for the current fiscal year, the estimate is $4.21 on $1.69 billion in revenues [7] Market Performance - AdvanSix shares have increased by approximately 2.9% since the beginning of the year, while the S&P 500 has gained 4% [3] - The stock currently holds a Zacks Rank of 3 (Hold), indicating expected performance in line with the market in the near future [6] Industry Outlook - The Chemical - Specialty industry, to which AdvanSix belongs, is currently ranked in the bottom 28% of over 250 Zacks industries, suggesting potential challenges ahead [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact AdvanSix's stock performance [5]

Sales Performance - 4Q24 sales were $329 million, down 14% year-over-year, primarily due to a 16% decrease in sales volume[8] - Full year 2024 sales totaled $1.52 billion, a decrease of approximately 1% compared to 2023, driven by a 2% decrease in volume[4] - Total sales for the three months ended December 31, 2024, were $329,063,000, a decrease from $382,208,000 in the same period of 2023, representing a decline of approximately 13.9%[26] Net Income and Earnings - Net income for FY 2024 was $44.1 million, down $10.5 million from the prior year, with diluted earnings per share of $1.62[5] - Net income for the twelve months ended December 31, 2024, was $44,149,000, down from $54,623,000 in 2023, indicating a decrease of about 19.2%[26] - Net income for Q4 2024 was $352 million, a significant recovery from a loss of $5,082 million in Q4 2023[34] - Adjusted net income for the twelve months ended December 31, 2024, was $53,318 million, compared to $59,929 million in 2023[35] - Basic EPS for the twelve months ended December 31, 2024, was $1.65, down from $2.00 in 2023, while diluted EPS was $1.62 compared to $1.95[35] EBITDA and Margins - Adjusted EBITDA for FY 2024 was $142.1 million, a decrease of $11.4 million year-over-year, resulting in an adjusted EBITDA margin of 9.4%[4] - Adjusted EBITDA for the twelve months ended December 31, 2024, was $142,116 million, down from $153,559 million in 2023, reflecting a margin of 9.4% compared to 10.0%[34] Cash Flow and Liquidity - Cash flow from operations for FY 2024 increased to $135.4 million, up $17.9 million from the previous year[4] - Cash and cash equivalents at the end of the period were $19,564,000, down from $29,768,000 at the end of 2023, reflecting a decrease of approximately 34.3%[30] - Free cash flow for the three months ended December 31, 2024, was $29,816,000, compared to $21,817,000 in the same period of 2023, showing an increase of about 36.5%[32] - The company reported a net cash provided by operating activities of $64,165,000 for the three months ended December 31, 2024, compared to $60,169,000 in the same period of 2023, an increase of approximately 3.3%[30] Expenses and Liabilities - The company’s selling, general and administrative expenses for the twelve months ended December 31, 2024, were $94,023,000, slightly down from $95,538,000 in 2023, indicating a decrease of about 1.6%[26] - The company’s interest expense for the twelve months ended December 31, 2024, was $11,311,000, up from $7,485,000 in 2023, reflecting an increase of approximately 51.5%[26] - Total liabilities rose to $820,270,000 as of December 31, 2024, compared to $756,783,000 in 2023, representing an increase of about 8.4%[25] Future Projections - The company expects a 10% increase in sales volume for 2025, despite a slower start to the year[14] - Capital expenditures are projected to be between $140 million and $160 million in 2025, reflecting growth projects including the SUSTAIN program[14] - The anticipated pre-tax income impact of plant turnarounds is expected to be $25 to $30 million in 2025, down from approximately $58 million in 2024[14] Dividends - A quarterly cash dividend of $0.16 per share was declared, payable on March 24, 2025[16] Assets and Retained Earnings - Total assets increased to $1,594,920,000 as of December 31, 2024, from $1,496,020,000 in 2023, marking an increase of approximately 6.6%[25] - The company’s retained earnings increased to $631,541,000 as of December 31, 2024, from $605,067,000 in 2023, showing an increase of about 4.4%[25] Other Financial Impacts - The company incurred a pre-tax loss of approximately $1.2 million related to the exit from the Oben Holding Group S.A. alliance in Q3 2023[34] - The company reported a net pre-tax loss of $4.5 million from several transactions in 2023, including the exit from low-margin oximes products[34] - The company experienced an incremental unfavorable impact of approximately $15 million to pre-tax income due to maintenance expenses during a planned plant turnaround[40]

Core Viewpoint - AdvanSix Inc. (ASIX) is set to release its fourth-quarter 2024 results on February 21, with expectations of mixed performance due to various market factors and operational challenges [1][3]. Revenue Estimates - The Zacks Consensus Estimate for ASIX's sales in the upcoming quarter is $377.1 million, reflecting a decline of approximately 1.3% year-over-year [4]. - Nylon sales are estimated at $81 million, indicating a year-over-year increase of 3.5%, while Caprolactam sales are projected at $77 million, showing a decline of 6.7% [4]. - Ammonium Sulfate sales are expected to be $94 million, down 13.5% year-over-year, and Chemical Intermediates sales are estimated at $103 million, representing an 8.7% decline [5]. Factors Influencing ASIX Stock - AdvanSix benefits from a differentiated product portfolio and exposure to diverse end markets, with favorable demand and pricing expected to support performance [6]. - The nylon demand remains strong in engineered plastics and packaging applications, while the agricultural sector's fundamentals are positive for ammonium sulfate [8]. - The company experienced higher sales for nylon and ammonium sulfate in the third quarter, driven by strong demand for sulfur nutrition and favorable pricing [9]. Operational Challenges - The fourth-quarter performance may be negatively impacted by an extended turnaround, with an estimated $17 million unfavorable effect on pre-tax income due to maintenance and delayed ramp-up at the Hopewell site [10]. Earnings Prediction - The Earnings ESP for ASIX is -9.59%, and the Zacks Consensus Estimate for the fourth quarter indicates a loss of 37 cents, suggesting a lower likelihood of an earnings beat this season [12].

Group 1: Stock Performance - AdvanSix Inc.'s shares have increased by 21.2% over the past six months, outperforming the Zacks Chemicals Specialty industry's decline of 6.6% and the S&P 500's rise of approximately 3.9% during the same period [1] Group 2: Demand and Pricing Factors - The company is benefiting from a differentiated product portfolio, exposure to diverse end markets, and favorable demand and pricing, particularly in nylon and ammonium sulfate [2] - Improved nylon demand conditions and growth in differentiated products are expected to drive further gains for AdvanSix [2] Group 3: Financial Performance - In the third quarter of 2024, AdvanSix reported growth in both top and bottom lines, with operating cash flow increasing by around 175% year over year to $57.3 million and free cash flow rising by $31.1 million from the prior-year quarter to $26.8 million [3][4] - The company ended the third quarter with cash and cash equivalents of approximately $17.3 million, indicating a healthy balance sheet [4] Group 4: Dividend Information - AdvanSix offers a dividend yield of 2.4%, which is above the S&P 500's average yield of roughly 2%, and has a five-year annualized dividend growth rate of 31.9% [5] - The company's dividend is considered safe and reliable, supported by strong cash flows and sound financial health [5]